remdesivir (Q28209496)

From Wikidata
Jump to navigation Jump to search
chemical compound and antiviral drug
  • GS-5734
  • 2-ethylbutyl (2S)-2-({[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl}amino)propanoate
  • Veklury
edit
Language Label Description Also known as
English
remdesivir
chemical compound and antiviral drug
  • GS-5734
  • 2-ethylbutyl (2S)-2-({[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl}amino)propanoate
  • Veklury

Statements

0 references
Remdesivir.svg
512 × 432; 11 KB
0 references
602.2253987099999 dalton
0 references
C₂₇H₃₅N₆O₈P
0 references
Nc3ncnn2c3ccc2C(C#N)(C1O)OC(C1O)CO[P](=O)(NC(C)C(=O)OCC(CC)CC)Oc4ccccc4
0 references
CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
0 references
1 reference
22 January 2022
The antiviral remdesivir should not be used as treatment for hospitalized Covid-19 patients, the World Health Organization said Thursday, only a month after the Food and Drug Administration approved the drug to treat patients over age 12 who are hospitalized with Covid-19. (English)
1 reference
22 January 2022
Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (English)
1 reference
FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)
2 references
22 January 2022
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. (English)
22 January 2022
However, the clinical efficacy of remdesivir for COVID-19 remains contentious, as several trials have not found statistically significant differences in either time to clinical improvement or mortality between remdesivir-treated and control groups. (English)
1 reference
22 January 2022
Although remdesivir performed well in preclinical studies, it did not meet efficacy endpoints in a randomized trial conducted during an Ebola outbreak. (English)
Remdesivir
0 references

Identifiers

0 references
0 references
EMEA/H/C/005622
0 references
0 references
 
edit
    edit
    edit
      edit
        edit
          edit
            edit
              edit